Optimizing Treatment Outcomes in HIV-Infected Patients with Substance Abuse Issues
The DOI matches its Crossref record.
Abstract
Drug abuse is associated with poorer virologic and clinical outcomes for patients with human immunodeficiency virus (HIV) infection. Limited evidence, primarily from in vitro and animal studies, shows that some abused drugs (e.g., opioids) may have direct effects on HIV pathology and the immune response to infection, but the clinical effects are not known. Clinical data indicate that the primary effect of drug abuse on HIV disease progression is mediated via factors that may limit access and/or adherence to highly active antiretroviral therapy (HAART). Drug abuse is associated with reduced adherence to HAART, which is strongly correlated with poorer virologic and clinical outcomes. However, the virologic and clinical effects of HAART are generally equivalent among drug abusers and non-drug abusers who adhere to therapy. These results underscore the importance of integrating medical and substance abuse interventions for HIV-positive drug abusers, to improve adherence to HAART and optimize outcomes of treatment for HIV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Management of HIV infection in patients with substance use problems
Nijhawan, A., Kim, S., & Rich, J. D. (2008) · Current Infectious Disease Reports · doi:10.1007/s11908-008-0068-x · Cited by 20
Behavioral and Other Characteristics Associated with HIV Viral Load in an Outpatient Clinic
Sacamano, P. L., & Farley, J. E. (2016) · PLOS ONE · doi:10.1371/journal.pone.0166016 · Cited by 13
Vetrova, M., Lodi, S., Rateau, L., Patts, G., Blokhina, E., Palatkin, V., Yaroslavtseva, T., Toussova, O., Bushara, N., Bendiks, S., et al. (2022) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2022.103600 · Cited by 11
Metadata
- Authors
- Celentano, D. D., & Lucas, G.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-15
- Volume
- 45
- Issue
- Supplement_4
- Pages
- S318-S323
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2049304391
- Cited by
- 36
- References
- 0
- FWCI
- 1.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.